Page 11 - செயலில் மருந்து மூலப்பொருள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Shares of Everest Organics hit a 20 per cent upper circuit limit of Rs 399.50, also its record high on the BSE in Tuesday s session after the company announced a successful development of Posaconazole API (Active Pharmaceutical Ingredient) used for the treatment of Black Fungus. The trading volumes on the counter jumped nearly 10-fold with around 76,000 equity shares having changed hands on the BSE, as against an average sub 8,000 shares that were traded in the past two weeks. There were pending buy orders for 24,195 shares, the exchange data shows. Posaconazole is a triazole antifungal agent indicated for treating mucormycosis, popularly known as Black Fungus, as part of post-Covid complications. The company is in the advanced stage of commercializing the same, Everest Organics said in a press release.

Andhra pradeshDrug administrationEverest organicsActive pharmaceutical ingredientBlack fungusActive pharma intermediatesUnited state foodஆந்திரா பிரதேஷ்எவரெஸ்ட் ஆர்க்யாநிக்ஸ்செயலில் மருந்து மூலப்பொருள்கருப்பு பூஞ்சைஒன்றுபட்டது நிலை உணவு